Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARNI in Type 2 Diabetes With and Without Diastolic Dysfunction
NCT03744975Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- May 2018
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in type 2 diabetes mellitus (T2DM), diastolic dysfunction, sponsored by Mayo Clinic. Started May 2018; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
type 2 diabetes mellitus (T2DM)diastolic dysfunction
Beyond the preview
Go deeper on NCT03744975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03744975.